Learn More
Medchemexpress LLC 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-((3S)-3-piperidinylmethyl)oxy)-2-methyl-3-butyn-2-ol | 937174-76-0 | MFCD14105605 | 98.5% | 425.48 g/mol | C21H27N7O3 | 25 MG

Supplier: Medchemexpress LLC HY1024925MG
GSK-690693 is a small-molecule, ATP-competitive pan-Akt inhibitor used for biochemical and cell-based research into PI3K/Akt signaling. It inhibits Akt1, Akt2, and Akt3 with low nanomolar potency (IC50s: 2 nM, 13 nM, 9 nM). The compound has molecular formula C21H27N7O3 and a molecular weight of 425.48 g/mol, and is supplied as a high-purity solid for laboratory research.
- Inhibits Akt1, Akt2, and Akt3 with low nanomolar potency.
- ATP-competitive mechanism of action.
- Suitable for biochemical and cell-based assays.
- Supplied as a high-purity solid (~98.5%).
- Molecular formula C21H27N7O3; molecular weight 425.48 g/mol.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.